Literature DB >> 16468327

[Identification of two novel mutations in ADAMTS13 gene in a patient with hereditary thrombotic thrombocytopenic purpura].

Fang Liu1, Jie Jin, Ning-zheng Dong, Yun-gui Wang, Chang-geng Ruan.   

Abstract

OBJECTIVE: To investigate the gene mutations of ADAMTS13 in a highly suspected hereditary thrombocytopenic purpura (TTP) patient, and then make a progressive diagnosis and adjust the plan of therapy.
METHODS: ADAMTS13 activity and inhibitor were determined by residual-collagen binding assay during several episodes. Genomic DNA extracted from the proband's peripheral blood was used for amplification of 29 exons and exon/intron boundaries of ADAMTS13 by PCR. The PCR products were screened by direct sequencing and the gene alterations were further confirmed by direct sequencing in her family members. RESULT: The activity of the proband's ADAMTS13 was significantly reduced while no inhibitor was found. Two novel missense mutations were found in the TSPI repeated motif domain of ADAMTS13. In both mutations, thymine substituted for cytidine, resulting in the substitution of leucine for serine in nt 2708, exon 21 (codon S903L), and tryptophan for arginine in nt 3283, exon 25(codon R1095W). These two mutations were revealed as each heterozygote in the proband's parents.
CONCLUSION: The deficiency of ADAMTS13 caused by two homozygote missense mutations might be responsible for episode of this TTP patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16468327

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  7 in total

1.  The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Kejian Zhang; Fanggeng Zou; Benjamin Laskin; Christopher E Dandoy; Kasiani C Myers; Adam Lane; Jaroslav Meller; Mario Medvedovic; Jenny Chen; Stella M Davies
Journal:  Blood       Date:  2015-11-24       Impact factor: 22.113

2.  First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene.

Authors:  Sheng-Chieh Chou; Dong-Tasmn Lin; Ching-Yeh Lin; Ying-Chih Huang; Han-Ni Hsieh; Ming-Ching Shen
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

Review 3.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 4.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

5.  ADAMTS13 gene mutations in children with hemolytic uremic syndrome.

Authors:  Hyoung Soo Choi; Hae Il Cheong; Nam Keun Kim; Doyeun Oh; Hye Won Park
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

Review 6.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

7.  Application of high-throughput sequencing for hereditary thrombocytopenia in southwestern China.

Authors:  Luying Zhang; Jie Yu; Ying Xian; Xianhao Wen; Xianmin Guan; Yuxia Guo; Mingzhu Luo; Ying Dou
Journal:  J Clin Lab Anal       Date:  2021-07-08       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.